Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Exudative Age Related Macular Degeneration”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Large-scale testing (Phase 3)Temporarily pausedNCT00460967
What this trial is testing

Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis

Who this might be right for
Age-Related Maculopathy
OccuLogix 325
Not applicableActive Not RecruitingNCT06125977
What this trial is testing

Impact of Non-Exudative Type 1 MNV on AMD Progression

Who this might be right for
Age-Related Macular DegenerationNeovascularization, Choroidal
University of Utah 73
Testing effectiveness (Phase 2)Ended earlyNCT02348359
What this trial is testing

X-82 to Treat Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration (AMD)Macular DegenerationExudative Age-related Macular Degeneration+5 more
Tyrogenex 157
Testing effectiveness (Phase 2)UnknownNCT05380492
What this trial is testing

Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-related Macular DegenerationGeographic Atrophy
Perceive Biotherapeutics, Inc. 45
Testing effectiveness (Phase 2)Study completedNCT00935883
What this trial is testing

Complement Inhibition With Eculizumab for the Treatment of Non-Exudative Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Philip J. Rosenfeld, MD, PhD 60
Not applicableUnknownNCT00926861
What this trial is testing

Posterior Macular Adhesion: A Potential Risk Factor for Non-exudative Age Related Macular Degeneration (AMD) to Develop Exudative AMD

Who this might be right for
Dry Age-related Macular DegenerationDetachment of the Posterior Hyaloid
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 320
Not applicableStudy completedNCT01404845
What this trial is testing

Macular Pigment Density Evolution in Unilateral Wet AMD Versus Non AMD Patients With or Without Lutein and Zeaxanthine Supplementation

Who this might be right for
Exudative Age-related Macular Degeneration
Affordance 200
Early research (Phase 1)Study completedNCT01013376
What this trial is testing

A Pilot Study of the Safety of MC-1101 in Both Normal Volunteers and Patients With Early Dry AMD

Who this might be right for
Age-Related Macular Degeneration
MacuCLEAR, Inc. 31
Not applicableEnded earlyNCT04764656
What this trial is testing

Observational Study to Evaluate Fluid Resolution and Effectiveness of Brolucizumab for nAMD in Portugal

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Novartis Pharmaceuticals 81
Post-approval studies (Phase 4)UnknownNCT01213667
What this trial is testing

Genetics in Non-response to Anti-VEGF Treatment in Exudative AMD

Who this might be right for
Macular Degeneration
University of Cologne 110
Not applicableUnknownNCT03893474
What this trial is testing

Quality-Assured Follow-up of Quiescent Neovascular Age -Related maculaR dEgeneration by Non-medical Practitioners

Who this might be right for
AMD
Moorfields Eye Hospital NHS Foundation Trust 742
Not applicableUnknownNCT00380172
What this trial is testing

Long-Term Efficacy in AMD of Rheopheresis in North America

Who this might be right for
Macular Degeneration
OccuLogix 120
Large-scale testing (Phase 3)UnknownNCT02127463
What this trial is testing

Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular Degeneration

Who this might be right for
Non-Exudative Age Related Macular Degeneration
MacuCLEAR, Inc. 60
Not applicableUnknownNCT01310686
What this trial is testing

Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) Therapy

Who this might be right for
Wet AMD
West Coast Retina Medical Group, Inc. 40
Not applicableLooking for participantsNCT07446582
What this trial is testing

Real-World Evaluation of AI Enabled Multi-Spectral Imaging (MSI) for AMD Biomarker Detection

Who this might be right for
Age-Related (Dry) Macular Degeneration
AI-Spectral 1,000
Not applicableStudy completedNCT04543331
What this trial is testing

Observational Study to Evaluate Fluid Resolution and Effectiveness in Patients Receiving Beovu in Neovascular Age-related Macular Degeneration and Visual Impairment Due to Diabetic Macular Edema

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)Diabetic Macular Edema (DME)
Novartis Pharmaceuticals 572
Not applicableStudy completedNCT04169802
What this trial is testing

Study Evaluating Retinal Health Monitoring System Visual Acuity Module.

Who this might be right for
Age Related Macular Degeneration
Kubota Vision Inc. 25
Post-approval studies (Phase 4)Study completedNCT01896284
What this trial is testing

Study to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth Factor

Who this might be right for
Wet Macular Degeneration
Barcelona Macula Foundation 46
Not applicableUnknownNCT04469140
What this trial is testing

Non Exudative AMD Imaged With SS-OCT- Extension

Who this might be right for
Dry Macular Degeneration
Boston Image Reading Center 450
Not applicableStudy completedNCT00088192
What this trial is testing

Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Eyetech Pharmaceuticals
Load More Results